Literature DB >> 8358792

A kinase-independent function of Lck in potentiating antigen-specific T cell activation.

H Xu1, D R Littman.   

Abstract

The lymphocyte-specific cytoplasmic protein-tyrosine kinase p56lck (Lck) is essential for T cell development and activation. Its association with the co-receptor molecules, CD4 and CD8, is required for potentiation of antigen-specific signals through the T cell antigen receptor. To study the mechanism of action of Lck, hybrid molecules consisting of the extracellular and transmembrane domains of CD4 fused to Lck or other Src family kinases were analyzed in an antigen-specific, CD4-dependent T cell hybridoma. Surprisingly, a chimera with a deletion of the Lck kinase domain was more active than the full-length protein. In contrast, point mutations in residues required for SH2 or kinase function resulted in moderately decreased activity, while a combination of these mutations rendered the chimera largely inactive. Different domains of CD4-associated Lck therefore have distinct functions that can independently contribute to T cell activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358792     DOI: 10.1016/0092-8674(93)90511-n

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  73 in total

1.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor.

Authors:  B K Cho; K C Lian; P Lee; A Brunmark; C McKinley; J Chen; D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

3.  Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4.

Authors:  Yiyuan Yin; Xin Xiang Wang; Roy A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

4.  Functional evidence for TCR-intrinsic specificity for MHCII.

Authors:  Heather L Parrish; Neha R Deshpande; Jelena Vasic; Michael S Kuhns
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 5.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

6.  The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.

Authors:  L Racioppi; G Matarese; U D'Oro; M De Pascale; A M Masci; S Fontana; S Zappacosta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

7.  Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases.

Authors:  J Wong; D Straus; A C Chan
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

8.  Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways.

Authors:  A H Wong; N W Tam; Y L Yang; A R Cuddihy; S Li; S Kirchhoff; H Hauser; T Decker; A E Koromilas
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

9.  Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain.

Authors:  I Joung; T Kim; L A Stolz; G Payne; D G Winkler; C T Walsh; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 10.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.